• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OnKure Therapeutics, Inc. - Class A Common Stock (NQ:OKUR)

4.590 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160
Open 4.590
Bid (Size) 4.590 (900)
Ask (Size) 5.000 (100)
Prev. Close 4.590
Today's Range 4.590 - 4.590
52wk Range 1.700 - 4.900
Shares Outstanding 33,655,123
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss ↗
August 12, 2025
OnKure Therapeutics (OKUR) reported Q2 2025 EPS of -$1.14, beating estimates, with no revenue. Stock rose 1.5% after hours. Clinical progress on OKI-219 cancer drug remains on track for Q4 2025 data. 
Via Chartmill
Topics Earnings
News headline image
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
March 11, 2025
 
Via Benzinga

Performance

YTD
+55.1%
+55.1%
1 Month
+80.0%
+80.0%
3 Month
+63.9%
+63.9%
6 Month
+80.7%
+80.7%
1 Year
-3.2%
-3.2%

More News

Read More
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
January 17, 2025
Via Benzinga
News headline image
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm ↗
October 10, 2024
Via Benzinga
News headline image
This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
October 10, 2024
Via Benzinga

Frequently Asked Questions

Is OnKure Therapeutics, Inc. - Class A Common Stock publicly traded?
Yes, OnKure Therapeutics, Inc. - Class A Common Stock is publicly traded.
What exchange does OnKure Therapeutics, Inc. - Class A Common Stock trade on?
OnKure Therapeutics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OnKure Therapeutics, Inc. - Class A Common Stock?
The ticker symbol for OnKure Therapeutics, Inc. - Class A Common Stock is OKUR on the Nasdaq Stock Market
What is the current price of OnKure Therapeutics, Inc. - Class A Common Stock?
The current price of OnKure Therapeutics, Inc. - Class A Common Stock is 4.590
When was OnKure Therapeutics, Inc. - Class A Common Stock last traded?
The last trade of OnKure Therapeutics, Inc. - Class A Common Stock was at 03/26/26 04:15 PM ET
What is the market capitalization of OnKure Therapeutics, Inc. - Class A Common Stock?
The market capitalization of OnKure Therapeutics, Inc. - Class A Common Stock is 154.48M
How many shares of OnKure Therapeutics, Inc. - Class A Common Stock are outstanding?
OnKure Therapeutics, Inc. - Class A Common Stock has 154M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap